Aufgrund von Wartungsarbeiten steht JLUpub am 18.05.2026 von 8:00 Uhr bis vorraussichtlich 11:00 Uhr nicht zur Verfügung.
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------
Due to maintenance work, JLUpub will be unavailable on 18 May 2026 from 8.00 am until approximately 11.00 am.

HRS Cells and Tumor-Associated Macrophages as Dual Mediators of PD-1/PD-L1–Dependent CD8⁺ T Cell Suppression in Classical Hodgkin Lymphoma

Loading...
Thumbnail Image

Date

Further Contributors

Contributing Institutions

Publisher

Journal Title

Journal ISSN

Volume Title

Publisher

License

Abstract

Classical Hodgkin lymphoma (cHL) features rare Hodgkin/Reed–Sternberg (HRS) cells within an immune-dense microenvironment, yet refractory disease persists in a subset of patients. This thesis interrogates how PD-1/PD-L1 signaling suppresses CD8⁺ T-cell cytotoxic immunity by integrating tumor-intrinsic and microenvironmental mechanisms. We combined mechanistic co-cultures, PLA coupled to multiplex immunofluorescence (PLA/mIF) on FFPE tissues, and RNA-seq of tumor-educated macrophages to link cellular mechanism to tissue context. Using mechanistic co-cultures of antigen-specific CD8⁺ T cells with HRS cells, we show that MHC-I–intact HRS cells directly restrain CD8⁺ effector function through PD-1/PD-L1 engagement; both PD-1 blockade and HRS PD-L1 knockout enhanced CD8⁺ activation and killing. In complementary systems incorporating tumor-associated macrophages (TAMs), PD-L1⁺ macrophages suppressed CD8⁺ T-cell activity via PD-1, and this inhibition was partially reversed by PD-1 blockade. Proximity ligation assay combined with multiplex immunofluorescence on FFPE sections confirmed in situ PD-1/PD-L1 engagement at two interfaces: CD8⁺ - HRS, and CD8⁺-TAMs contacts. Notably, EBV-positive tumors exhibited higher interaction rates across both interfaces, consistent with preserved MHC-I and enriched myeloid niches. PLA/IF further demonstrated that in tumors with limited CD8–HRS contact, CD8⁺ T cells continued to form PD-1/PD-L1 interactions with macrophages, indicating that TAMs can function as alternative checkpoint partners when direct tumor engagement is reduced. Together, these data support a multilayered model in which HRS cells initiate checkpoint-mediated suppression that TAMs amplify and stabilize. Long-term co-cultures of HRS cells with PD-1–expressing cells revealed no sustained proliferative or survival advantage from PD-L1 ligation under nutrient-replete conditions, suggesting context dependence of PD-L1 reverse signaling. Finally, RNA-seq of macrophages exposed to HRS-conditioned media showed M2-like polarization with increased mediators such as VSIG4, MMP9, and PDGF ligands, reinforcing checkpoint-mediated suppression and impairing T-cell function. Together, these data support a layered model of immune evasion in cHL: HRS cells can initiate PD-1/PD-L1–dependent inhibition where MHC-I is intact, while M2-like TAMs act as compensatory/alternative partners that sustain suppression when direct CD8–HRS engagement is limited. This framework explains the variable efficacy of PD-1 blockade and supports macrophage-targeted therapies for more durable responses.

Link to publications or other datasets

Description

Notes

Original publication in

Original publication in

Anthology

URI of original publication

Forschungsdaten

Series

Citation